麻豆社

As the Medicines and Healthcare products Regulatory Agency (MHRA) embarks on a new phase in its leadership, and the new government seeks to improve UK regulatory standards across the board, this report brings together our industry鈥檚 contribution to shaping a globally leading UK regulatory framework for innovative medicines.